Paliperidone 6-Month Im Injection Suppliers & Bulk Manufacturers

Available Forms: Once-6-Month IM Injection

Available Strengths: 1,092 mg, 1,560 mg

Reference Brands: Invega Hafyera®(US)

Category: Antipsychotropic Drugs

Paliperidone 6-Month IM Injection is available in Once-6-Month IM Injection and strengths such as 1,092 mg, 1,560 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Paliperidone 6-Month IM Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Paliperidone 6-Month IM Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Paliperidone 6-month intramuscular injection (brand name: Invega Hafyera) is FDA-approved in the United States for the maintenance treatment of schizophrenia in adults stabilized on 1-month or 3-month paliperidone formulations. It is designed to improve adherence and reduce relapse by offering long-term dosing. In the European Union, this 6-month version is not yet widely approved, requiring a new EMA submission via the centralized procedure. Regulatory requirements include GMP-compliant long-acting injectable technology, bridging pharmacokinetic studies, and thorough safety evaluations. U.S. labelling carries boxed warnings for elderly dementia-related psychosis. Explore sourcing options at Pharmatradz.com — your B2B pharma partner.